Enzyme inhibitor combined with chemotherapy delays glioblastoma growth

(University of Alabama at Birmingham) In animal experiments, a human-derived glioblastoma significantly regressed when treated with the combination of an experimental enzyme inhibitor and the standard glioblastoma chemotherapy drug, temozolomide.